Concepedia

Nonclinical evaluation of IQG-607, an anti-tuberculosis candidate with potential use in combination drug therapy

Valnês S. Rodrigues-Junior, Anne Drumond Villela, Bruno Lopes Abbadi, Nathalia Sperotto, Kenia Pissinate, Jaqueline Nascimento Picada, Juliana Bondan da Silva, Cristiano Valim Bizarro, Pablo Machado, Luiz Augusto Basso

Regulatory Toxicology and Pharmacology · 2019 · 16 citations · 19 references

DOIFull text

Open access

Concepts

References

19

Global tuberculosis report (2014)

L.A. Gabbasova, E.R. Experts Who · 2014 · 13.2K citations

, , +12

Revised methods for the Salmonella mutagenicity test

Dorothy M. Maron, Bruce N. Ames · Mutation Research/Environmental Mutagenesis and Related Subjects · 1983 · 7.4K citations

, , +7

Inhibition of Cytochrome P450 (CYP450) Isoforms by Isoniazid: Potent Inhibition of CYP2C19 and CYP3A

Zeruesenay Desta, Nadia Soukhova, David A. Flockhart · Antimicrobial Agents and Chemotherapy · 2001 · 181 citations · Full text

, , +17

Isoniazid is a mechanism-based inhibitor of cytochrome P 450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes

Junsheng Wang, Pertti J. Neuvonen, Janne T. Backman · European Journal of Clinical Pharmacology · 2001 · 156 citations

, , +16

Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice

J Grosset, C. Truffot-Pernot, Christian Lacroix et al. · Antimicrobial Agents and Chemotherapy · 1992 · 147 citations · Full text

, , +14